Beta-blockers for congestive heart failure in children

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2009, Pages

  Frobel, Anne Kristina ^a   Hulpke Wette, Martin ^b   Schmidt, Klaus G ^c   Läer, Stephanie ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Outpatient Clinic for Paediatrics   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Adrenergic beta antagonists *therapeutic use ; Child; Heart failure *drug therapy ; Humans; Randomized controlled trials as topic

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NEUROHORMONE; PLACEBO; PROPRANOLOL;

ADVERSE OUTCOME; AGE DISTRIBUTION; BRADYCARDIA; CARDIOMYOPATHY; CARDIOVASCULAR PARAMETERS; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; COUGHING; DISEASE SEVERITY; DRUG CHOICE; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; FITNESS; FORWARD HEART FAILURE; HEART DEATH; HEART GRAFT; HEART HEMODYNAMICS; HEART LEFT RIGHT SHUNT; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HEART RATE VARIABILITY; HEMODYNAMICS; HUMAN; LOW DRUG DOSE; LUNG DISEASE; NOSE FEEDING; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PULMONARY OVERCIRCULATION; QUALITY OF LIFE; RESPIRATORY TRACT INFECTION; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC DYSFUNCTION; TREATMENT DURATION; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 70249122706     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007037.pub2     Document Type: Review

References (31)

1. Azeka E, Franchini Ramires JA, Valler C, Alcides Bocchi E. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. Journal of the American College of Cardiology 2002;40(11):2034-2038 (Pubitemid 35425373)
2. Buchhorn R, Hulpke-Wette M, Hilgers R, Bartmus D, Wessel A, Bürsch J. Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol. International Journal of Cardiology 2001;79(2-3):167-173
3. * Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, et al.Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007;298(10):1171-1179
4. Shaddy RE, Curtin EL, Sower B, Tani LY, Burr J, LaSalle B, et al.The Pediatric Randomized Carvedilol Trial in Children with Heart Failure: rationale and design. American Heart Journal 2002;144(3):383-389 (Pubitemid 35056081)
5. Kajimoto H, Ishigaki K, Okumura K, Tomimatsu H, Nakazawa M, Saito K, et al.Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circulation Journal 2006;70(8):991-994 (Pubitemid 44161734)
6. Suwa M, Ito T, Otake Y, Moriguchi A, Hirota Y, Kawamura K. Comparison of the therapeutic effects of the beta-blocking agent bisoprolol and the calcium-blocking agent diltiazem in patients with heart failure due to dilated cardiomyopathy. Japanese Circulation Journal 1996;60(10):767-773 (Pubitemid 26389512)
7. Albers S, Meibohm B, Mir TS, Läer S. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. British Journal of Clinical Pharmacology 2008;65(4):511-522
8. Arola A, Jokinen E, Ruuskanen O, Saraste M, Pesonen E, Kuusela AL, et al.Epidemiology of idiopathic cardiomyopathies in children and adolescents. A nationwide study in Finland. American Journal of Epidemiology 1997;146(5):385-393 (Pubitemid 27377515)
9. Bruns LA, Chrisant MK, Lamour JM, Shaddy RE, Pahl E, Blume ED, et al.Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. Journal of Pediatrics 2001;138(4):505-511 (Pubitemid 32319723)
10. Buchhorn R, Bartmus D, Siekmeyer W, Hulpke-Wette M, Schulz R, Bürsch J. Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts. American Journal of Cardiology 1998;81(11):1366-1368 (Pubitemid 28268680)
11. Buitelaar JK, van der Gaag RJ, Swaab-Barneveld H, Kuiper M. Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects. Journal of Child Psychology and Psychiatry, and Allied Disciplines 1996;37(5):587-595 (Pubitemid 26196492)
12. European Medicines Agency (EMEA). ICH Topic E 11, Clinical investigation of medicinal products in the paediatric population. Available from http://www.emea.europa.eu/pdfs/human/ich/271199en.pdf (accessed September 14 2008) 2001.
13. The Task Force for the diagnosis and treatment of CHF of the European Society of Cardiology. Guidelines for the diagnosis and treatment of Chronic Heart Failure: full text (update 2005). Available from http://www.escardio.org/ guidelines-surveys/esc-guidelines/Documents/CHF/guidelines-CHF-FT-2005.pdf (accessed October 22 2008) 2005.
14. Gachara N, Prabhakaran S, Srinivas S, Farzana F, Krishnan U, Shah MJ. Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: a preliminary report. Indian Heart Journal 2001;53(1):74-78 (Pubitemid 32591409)
15. Giardini A, Formigari R, Bronzetti G, Prandstraller D, Donti A, Bonvicini M, et al.Modulation of neurohormonal activity after treatment of children in heart failure with carvedilol. Cardiology in the Young 2003;13(4):333-336 (Pubitemid 41630871)
16. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Review of Interventions 5.0.0 [updated February 2008]. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. Available from http://www.cochrane-hand-book.org/ (accessed October 22 2008). The Cochrane Collaboration, 2008.
17. Kay JD, Colan SD, Graham TP Jr. Congestive heart failure in pediatric patients. American Heart Journal 2001;142(5):923-928 (Pubitemid 33016213)
18. Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology - drug disposition, action, and therapy in infants and children. New Englang Journal of Medicine 2003;349(12):1157-1167 (Pubitemid 37122329)
19. Klein L, O'Connor CM, Gattis WA, Zampino M, de Luca L, Vitarelli A, et al.Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations. American Journal of Cardiology 2003;92(11):1378. (Pubitemid 36555737)
20. Kulikowska A, Boslaugh SE, Huddleston CB, Gandhi SK, Gumbiner C, Canter CE. Infectious, malignant, and autoimmune complications in pediatric heart transplant recipients. Journal of Pediatrics 2008;152(5):671-677
21. Levi D, Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Current Opinion in Cardiology 2001;16(2):77-83. (Pubitemid 32210353)
22. Läer S, Mir TS, Behn F, Eiselt M, Scholz H, Venzke A, et al.Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters. American Heart Journal 2002;143(5):916-922 (Pubitemid 34595354)
23. Morales DL, Dreyer WJ, Denfield SW, Heinle JS, McKenzie ED, Graves DE, et al.Over two decades of pediatric heart transplantation: how has survival changed?. Journal of Thoracic & Cardiovascular Surgery 2007;133(3):632-639
24. American Heart Association. 1994 Revisions to Classification of Functional Capacity and Objective Assessment of Patients With Diseases of the Heart. Available from http://www.americanheart.org/presenter.jhtml?identifier= 1712 (accessed September 14 2008) 1994.
25. Picchio FM, Formigari R, Balducci A. Pediatric heart failure. Minerva Cardioangiologica 2008;56(3):311-319
26. Ross RD, Daniels SR, Schwartz DC, Hannon DW, Shukla R, Kaplan S. Plasma norepinephrine levels in infants and children with congestive heart failure. American Journal of Cardiology 1987;59(8):911-914 (Pubitemid 17061313)
27. Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatric Cardiology 1992;13(2):72-75
28. Rusconi P, Gómez-Marín O, Rossique-González M, Redha E, Marín JR, Lon-Young M, et al.Carvedilol in children with cardiomyopathy: 3-year experience at a single institution. Journal of Heart & Lung Transplantation 2004;23(7):832-838 (Pubitemid 38953866)
29. Shaddy RE, Tani LY, Gidding SS, Pahl E, Orsmond GS, Gilbert EM, et al.Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multi-institutional experience. Journal of Heart & Lung Transplantation 1999;18(3):269-274 (Pubitemid 29177904)
30. Webster G, Zhang J, Rosenthal D. Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: a retrospective, cross-sectional study. BMC Cardiovascular Disordorders 2006;6:23. (Pubitemid 44192779)
31. Williams RV, Tani LY, Shaddy RE. Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction. Journal of Heart & Lung Transplantation 2002;21(8):906-909